注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Sutro Biopharma, Inc是一家临床阶段的从事药物研发和生产的公司。该公司专注于部署其集成的无细胞蛋白质合成平台XpressCF,为癌症和自身免疫性疾病创造各种蛋白质疗法。该公司致力于采用强力手段设计治疗方法,包括基于细胞因子的治疗方法、免疫肿瘤学(I/O)药物、抗体药物复合物(ADC)和主要针对临床验证靶点的双特异性抗体。其候选产品包括STRO-001和STRO-002。STRO-001是一种针对癌症靶点CD74的ADC,适用于多发性骨髓瘤和非霍奇金淋巴瘤(NHL)患者。STRO-002是一种针对叶酸受体(FolRa)的ADC,适用于卵巢癌和子宫内膜癌患者。通过将接头弹头放置在抗体内的特定位置,对STRO-001和STRO-002的设计根据治疗指数进行了优化。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
William J. Newell | 64 | 2009 | CEO & Director |
Connie L. Matsui | 68 | 2019 | Independent Chair of the Board |
Joseph M. Lobacki | 64 | 2017 | Independent Director |
Lawrence Fong | - | - | Co-Chair of Clinical Advisory Board & Member of Scientific Advisory Board |
Carlos V. Paya | 64 | 2020 | Chair of the Scientific Advisory Board |
Daniel H. Petree | 67 | 2009 | Independent Director |
Heidi Hunter | 65 | 2021 | Independent Director |
Trevor J. Hallam | 64 | 2010 | Member of Scientific Advisory Board |
Michael P. Dybbs | 48 | 2018 | Independent Director |
Lainie P. Martin | - | 2020 | Member of the Clinical Advisory Board |
Ana Oaknin Benzaquen | - | 2021 | Member of the Clinical Advisory Board |
John Gordon Freund | 69 | 2014 | Independent Director |
Amrita Krishnan | - | - | Member of Clinical Advisory Board |
Robert T. Abraham | 69 | - | Member of Scientific Advisory Board |
John P. Leonard | - | - | Member of Clinical Advisory Board |
James P. Panek | 69 | 2020 | Independent Director |
Jon Marc Wigginton | 61 | 2020 | Independent Director |
Stanley R. Frankel | 63 | - | Member of Scientific Advisory Board |
R. Wendel Naumann | - | - | Member of Clinical Advisory Board |
Richard T. Penson | - | - | Member of Clinical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核